Search research articles
Contact Us
Filters
Showing results (591-600 of 618) with videos related to
Page
of 62
Sort By:
Signal Transduction and Targeted Therapy
|
February 2, 2022
EPHA2 mediates PDGFA activity and functions together with PDGFRA as prognostic marker and therapeutic target in glioblastoma
Qu-Jing Gai, Zhen Fu, Jiang He, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 27, 2020
Effect of rhG-CSF Combined With Decitabine Prophylaxis on Relapse of Patients With High-Risk MRD-Negative AML After HSCT: An Open-Label, Multicenter, Randomized Controlled Trial
Lei Gao, Yanqi Zhang, Sanbin Wang, et al.
British Journal of Haematology
|
May 27, 2020
Development and validation of a prediction model (AHC) for early identification of refractory thrombotic thrombocytopenic purpura using nationally representative data
Ruo-Yun Gui, Qiu-Sha Huang, Xuan Cai, et al.
The Lancet. Oncology
|
November 28, 2017
Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study
Wen-Zhao Zhong, Qun Wang, Wei-Min Mao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 7, 2018
The Unique Spatial-Temporal Treatment Failure Patterns of Adjuvant Gefitinib Therapy: A Post Hoc Analysis of the ADJUVANT Trial (CTONG 1104)
Song-Tao Xu, Jun-Jie Xi, Wen-Zhao Zhong, et al.
Science Translational Medicine
|
April 8, 2026
Pharmacological activation of WASp potentiates macrophage phagocytosis and enhances ibrutinib efficacy against mouse models of brain tumors
Yue Cheng, Tianran Li, Mengru Wang, et al.
Nature Communications
|
July 7, 2021
Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan
Cesheng Li, Ding Yu, Xiao Wu, et al.
Cell Research
|
July 9, 2021
Pericytes augment glioblastoma cell resistance to temozolomide through CCL5-CCR5 paracrine signaling
Xiao-Ning Zhang, Kai-Di Yang, Cong Chen, et al.
The Journal of Pathology
|
June 20, 2022
A map of the spatial distribution and tumour-associated macrophage states in glioblastoma and grade 4 IDH-mutant astrocytoma
Wen Yin, Yi-Fang Ping, Fei Li, et al.
Cancer Research
|
September 25, 2025
TRIM49 Deficiency Stabilizes a Galectin-3/EGR1 Transcriptional Complex that Drives Invasiveness of Gastric Adenocarcinoma
Zhong-Yi Qin, Lin-Rong Che, Shuoran Tian, et al.
Page
of 62
Search research articles
Search
Showing results (591-600 of 618) with videos related to
Sort By:
Page
of 62
Signal Transduction and Targeted Therapy
|
February 2, 2022
EPHA2 mediates PDGFA activity and functions together with PDGFRA as prognostic marker and therapeutic target in glioblastoma
Qu-Jing Gai, Zhen Fu, Jiang He, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology
|
October 27, 2020
Effect of rhG-CSF Combined With Decitabine Prophylaxis on Relapse of Patients With High-Risk MRD-Negative AML After HSCT: An Open-Label, Multicenter, Randomized Controlled Trial
Lei Gao, Yanqi Zhang, Sanbin Wang, et al.
British Journal of Haematology
|
May 27, 2020
Development and validation of a prediction model (AHC) for early identification of refractory thrombotic thrombocytopenic purpura using nationally representative data
Ruo-Yun Gui, Qiu-Sha Huang, Xuan Cai, et al.
The Lancet. Oncology
|
November 28, 2017
Gefitinib versus vinorelbine plus cisplatin as adjuvant treatment for stage II-IIIA (N1-N2) EGFR-mutant NSCLC (ADJUVANT/CTONG1104): a randomised, open-label, phase 3 study
Wen-Zhao Zhong, Qun Wang, Wei-Min Mao, et al.
Journal of Thoracic Oncology : Official Publication of the International Association for the Study of Lung Cancer
|
December 7, 2018
The Unique Spatial-Temporal Treatment Failure Patterns of Adjuvant Gefitinib Therapy: A Post Hoc Analysis of the ADJUVANT Trial (CTONG 1104)
Song-Tao Xu, Jun-Jie Xi, Wen-Zhao Zhong, et al.
Science Translational Medicine
|
April 8, 2026
Pharmacological activation of WASp potentiates macrophage phagocytosis and enhances ibrutinib efficacy against mouse models of brain tumors
Yue Cheng, Tianran Li, Mengru Wang, et al.
Nature Communications
|
July 7, 2021
Twelve-month specific IgG response to SARS-CoV-2 receptor-binding domain among COVID-19 convalescent plasma donors in Wuhan
Cesheng Li, Ding Yu, Xiao Wu, et al.
Cell Research
|
July 9, 2021
Pericytes augment glioblastoma cell resistance to temozolomide through CCL5-CCR5 paracrine signaling
Xiao-Ning Zhang, Kai-Di Yang, Cong Chen, et al.
The Journal of Pathology
|
June 20, 2022
A map of the spatial distribution and tumour-associated macrophage states in glioblastoma and grade 4 IDH-mutant astrocytoma
Wen Yin, Yi-Fang Ping, Fei Li, et al.
Cancer Research
|
September 25, 2025
TRIM49 Deficiency Stabilizes a Galectin-3/EGR1 Transcriptional Complex that Drives Invasiveness of Gastric Adenocarcinoma
Zhong-Yi Qin, Lin-Rong Che, Shuoran Tian, et al.
Page
of 62